下一个

自动播放

Rebiopsy and Acquired Mutations Following Progression in Non-Small Cell Lung Cancer

1 意见 • 07/14/23
分享
嵌入
administrator
administrator
订户
0

Anne S. Tsao, MD, Mark A. Socinski, MD, Corey J. Langer, MD, Alan B. Sandler, MD, and David Gandara, MD, discuss the need to perform a second biopsy to check for the loss or acquisition of mutations in non-small cell lung cancer following progression.

For more from this conversation: http://www.onclive.com/peer-ex....change/nsclc-advance

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放